Eden Research (LON:EDEN)

Eden Research (LON:EDEN)


Share Price
11.00 p
Change
-0.3 (-2.65 %)
Market Cap
£22.79 m
Proactive Investors - Run By Investors For Investors

Eden Research

Eden provides sustainable solutions for crop protection, animal health and consumer products.

Like humans and animals, plants have developed defences against disease, pests and various other threats. Essential oils are one component of these defence systems and these oils contain active molecules that help fight against disease, oxidative stress and insect predators. Eden has developed...

EPIC: EDEN
Market: AIM:EDEN
52-week High/Low: 13.92p / 9.00p
Sector: Chemicals
Market Cap: £22.79 m
Website: www.edenresearch.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Eden Research


Eden Research Snapshot

Eden’s plant protection products are suitable for a wide range of crops. With a focus on high-value fruits and vegetables where their efficacy and regulatory status make them ideally suited to solve the challenges faced by growers in today’s increasingly tough regulatory climate.
 

Foliar Disease Control
Eden has developed a range of fungicides targeting well-known plant diseases such as botrytis, powdery mildew, downey mildew and others.

The first of these products, 3AEY, a fungicide which targets botrytis, is currently being sold throughout the southern EU zone and Kenya.

Protected Glass House Crops
Many of the high-value fruits and vegetables that benefit from Eden’s products are produced in high-volume commercial greenhouses and poly-tunnels.

In addition to providing effective disease prevention and control, the safety profile of Eden’s products means that they are well-suited to environments in which worker exposure can be relatively high.

Soil Pests
Plant-parasitic nematodes are soil-dwelling worms measuring approximately 0.1-5 mm in length.

Nematode populations can cause considerable damage to a wide range of high value vegetable crops and horticultural species. The most severely affected plants include intensively-grown crops such as potatoes, tomatoes, carrots, grapevines and many perennial fruits that are grown under monoculture conditions, plus sugar beet and golf course turf. The financial cost of nematode damage for farmers, gardeners and owners of golf courses and sports fields is substantial. At present, effective nematode control requires an integrated approach including cultural, physical and chemical methods.

Post Harvest Applications
Eden’s objective is to improve fruit and vegetable quality by reducing storage soft rots.

These diseases are similar to the Botrytis disease in grapes where efficacy of Eden product 3AEY is already proven. Shelf life extension, lack of pesticide residues and improved produce quality are key objectives in this high-value market.

 

 

 

Board of Directors

Picture of Lykele van der Broek

Lykele van der BroekNon-Executive Chairman

Appointed
October 2017 (Non-Executive Director)
January 2018 (Non-Executive Chairman)


Background and experience
Lykele retired as a Member of the Board of Management of Bayer CropScience, a division of Bayer AG, in 2014, being responsible for the commercialisation of innovative agricultural products and services globally. Prior to this, he held senior international roles including the Head of Bayer CropScience’s BioScience division and President of the Bayer HealthCare Animal Health division.

Committee membership
AIM Compliance Committee (Chairman)
Nominations Committee (Chairman)
Remunerations Committee (Chairman)
Audit Committee


External appointments
Genus plc (Non-Executive Director)

 

 

Picture of Sean Smith

Sean SmithChief Executive Officer

Appointed
September 2014

Background and experience
Sean has a bachelors degree in microbiology and over 25 years of experience in the speciality chemicals and industrial biotechnology industries. He has held senior commercial leadership roles ranging from sales and marketing to business management and intellectual property licensing in blue chip companies such as Ciba (now BASF) and Honeywell. In recent years, Sean has focussed on technology commercialization through licensing and company formation working with Intellectual Ventures and several start-ups.

Committee membership
None

External appointments
None

 

 

Picture of Alex Abrey

Alex AbreyChief Financial Officer

Appointed
September 2007

Background and experience
Alex, a Chartered Certified Accountant, joined the Board in September 2007, having been Chief Accountant to Eden for the previous four years. He has acted as Financial Director to a diverse range of businesses including a financial and management consultancy business based in Oxfordshire, a medical waste management company and an intellectual property licensee involved in plastics manufacturing. Alex has seventeen years’ experience in both practice and industry.

Committee membership
None

External appointments
Ricewood Ltd (Director)

 

 

Picture of Robin Cridland

Robin CridlandNon-Executive Director

Appointed
May 2015

Background and experience
Rob currently serves as Chief Financial Officer and Company Secretary of Itaconix plc. He joined Itaconix in September 2008 from Renovo Group plc where he spent seven years as Executive Director of Finance and Business Development. He began his career at Coopers & Lybrand Deloitte, before moving on to senior transactional roles at Enskilda Securities and senior finance and transactional roles at GlaxoWellcome and GlaxoSmithKline. He was also a Governor and a Non-Executive Director of Cheadle Hulme School, Cheshire.

Committee membership
Audit Committee (Chairman)
Nominations Committee
AIM Compliance Committee
Remuneration Committee


External appointments
None 

 

Head Office & Operations Centre
6 Priory Court
Priory Court Business Park
Poulton
Cirencester
GL7 5JB

Tel: +44 (0) 1285 359555
Email: [email protected]

Corporate Name & Registered Office:
Eden Research plc
6 Priory Court,
Priory Court Business Park,
Poulton,
Cirencester
GL7 5JB
UK

Company No. 03071324

Financial Public Relations & Investor Relations
Nick Dibden
Powerscourt
1 Tudor Street
London
EC4Y 0AH
www.powerscourt-group.com

Nominated Advisor
Shore Capital and Corporate Limited
Bond Street House
14 Clifford Street
London
W1S 4JU
www.shorecap.co.uk
Broker
Shore Capital Stockbrokers Limited
Bond Street House
14 Clifford Street
London
W1S 4JU
www.shorecap.co.uk
Auditors
KPMG LLP
66 Queen Square
Bristol BS1 4BE
home.kpmg.com
Solicitors to the Company
DAC Beachcroft
100 Fetter Lane, 
London 
EC4A 1BN
www.dacbeachcroft.com

Registrars 
Link Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent
BR3 4TU
0871 6640300
www.signalshares.com

Head Office & Operations Centre

6 Priory Court
Priory Court Business Park
Poulton
Cirencester
GL7 5JB

Tel: +44 (0) 1285 359555
Email: [email protected]

Corporate Name & Registered Office:

Eden Research plc
6 Priory Court,
Priory Court Business Park,
Poulton,
Cirencester
GL7 5JB
UK

Company No. 03071324

Financial Public Relations & Investor Relations

Nick Dibden
Powerscourt
1 Tudor Street
London
EC4Y 0AH
www.powerscourt-group.com

 

Financial PR Advisor
Powerscourt Group
1 Tudor Street
London EC4Y 0AH
www.powerscourt-group.com

 

Columns Including EDEN

VIEW ALL

Market Reports Including EDEN

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use